Clinical Trial Update: Insulin Resistance And End Stage Renal Disease: The Role Of Retinol Binding Protein 4

View source ↗

Summary

This document provides a clinical trial update on the role of retinol binding protein 4 in insulin resistance and end-stage renal disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• End-stage Renal Disease
• Insulin Resistance

Snippet

Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia | Conditions: Insulin Resistance, Diabetes | Status: UNKNOWN